Sekisui Diagnostics
Sekisui Diagnostics, a global provider of innovative medical diagnostics to physicians and laboratories, has been committed to improving the lives of patients for over 30 years. We continue to invest in new diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. We are a leading provider of rapid tests in the U.S., and high throughput coagulation systems in Japan. We develop, manufacture, and supply over 1.7 billion tests each year to the global healthcare market through direct sales, our commercial distribution networks and our partners.
Contact Sekisui via their website
News archive
17/11/2020 SEKISUI Diagnostics Announces Launch of the OSOM® Flu Test in Europe...more
29/07/2020 SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity...more
28/07/2020 SEKISUI Diagnostics Reminds Us of The Importance of Vitamin D Testing and Treatment...more
08/06/2020 Sekisui Diagnostics Announces FDA Clearance for Influenza A&B rapid test...more
18/05/2020 Sekisui Diagnostics Helping In Fight Against COVID-19...more
06/04/2020 Sekisui Diagnostics Announces Distribution of SARS-CoV-2 Test...more
04/04/2020 Sekisui Diagnostics announces distribution agreement with Mesa Biotech...more
04/02/2020 Sekisui Chemical Co recognized as one of the Most Sustainable Corporations in the World...more
24/11/2019 Sekisui Diagnostics Opens $1.9 Million Bioprocess Innovation Centre...more
24/10/2019 Sekisui Invests $1.9m in New Bioprocess Innovation Centre in the UK...more
07/09/2019 Sekisui Diagnostics Announces FDA Clearance AcucyTM Influenza Test...more
11/09/2019 Sekisui Diagnostics Announces Launch of New Silaris® Molecular RSV Test...more
09/07/2019 Sekisui Diagnostics Announces Relocation of Global Headquarters...more
14/05/2019 Sekisui Diagnostics invests $1.9 million in new Maidstone BioProcess Innovation Centre...more
18/04/2019 Sekisui Diagnostics Announces the Launch of the FastPack® IP SHBG Test...more
28/02/2019 Sekisui Diagnostics PEI Expands with more Jobs...more
13/12/2018 Sekisui Diagnostics PEI in Canada's Top 100 Employers...more
26/09/2018 Sekisui Diagnostics joins the BioPartner programme...more
30/07/2018 Sekisui Diagnostics Receives SEKURE® HbA1c FDA Clearance...more
